Welcome to LookChem.com Sign In|Join Free
  • or
1-Piperazinecarboxylic acid, 3-(hydroxymethyl)-4-methyl-, 1,1-dimethylethyl ester, (3R)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

278788-67-3

Post Buying Request

278788-67-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

278788-67-3 Usage

Also known as

(R)-baclofen

Purpose

Medication used to treat muscle spasticity and spasms

Mechanism of action

Enhances the activity of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain, leading to muscle relaxation and reduced muscle spasticity

Chemical classification

Ester derivative of baclofen, a muscle relaxant and antispasmodic agent that acts on the central nervous system.

Check Digit Verification of cas no

The CAS Registry Mumber 278788-67-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,8,7,8 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 278788-67:
(8*2)+(7*7)+(6*8)+(5*7)+(4*8)+(3*8)+(2*6)+(1*7)=223
223 % 10 = 3
So 278788-67-3 is a valid CAS Registry Number.

278788-67-3Downstream Products

278788-67-3Relevant academic research and scientific papers

1, 7 - DIAZACARBAZOLES AND THEIR USE IN THE TREATMENT OF CANCER

-

Page/Page column 102, (2011/07/07)

The invention relates to 1, 7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk 1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.

FARNESYL PROTEIN TRANSFERASE INHIBITORS

-

Page/Page column 35-36, (2010/02/11)

Disclosed are compounds of formula (1.0), wherein R represents a cyclic moiety to which is bound an imodazolylalkyl group; R represents a carbamate, urea, amide or sulfonamide group; and the remaining substituents are as defined herein. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 278788-67-3